RIGEL PHARMACEUTICALS

Codice
RIGL
Risorse esterne
Opinione della community
Prezzo Variazione Volume
2.4 -0.83 €
(-25.70%)
62277
P/E Obiettivo ad 1anno
0 6.2 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 21
Sell : 11

LucaMazzu91 Raul Gardini Denise Brescia GMMoretti Simone Bonzanini francesco

Commenti


Notizie

Rigel Pharmaceuticals, Inc. (RIGL) Trading Down 7% on ... - The Cerbat Gem

Rigel Pharmaceuticals logo Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) traded down 7% during mid-day trading on Wednesday following a dissappointing earnings announcement. The company traded as low as $2.50 and last traded at $2.64, ... Leggi

Trading updates about Stock: Athene Holding Ltd.'s (ATH), Rigel ... - Is stories

Rigel Pharmaceuticals, Inc. (RIGL) observed trading -8.94% away from the 20-day moving average and -15.05% off from its 50-day simple moving average. Recently, the stock has been moved -12.24% from its 200-day simple moving average.altro » Leggi

Company Watch for Rigel Pharmaceutical (RIGL) - Stock Daily Review - Stock Daily Review

Investors may be closely watching the levels on shares of Rigel Pharmaceutical (RIGL). After a recent scan, we can see that last month's opinion signal is Strong.altro » Leggi

Price Review of Stocks: Rigel Pharmaceuticals, Inc.'s (RIGL) and ... - NYSE Journal (press release)

In recent trade look, shares of Rigel Pharmaceuticals, Inc. (RIGL) are at -44.75% from the 52-week high, and are keeping their distance at 24.74% from 52-week low. Currently, the company ROA is -73.00%. The number of outstanding shares currently held ... Leggi

Rigel Pharmaceuticals, Inc. (RIGL) added to 13 new portfolios - Post Analyst

Multiple company employees have indulged in significant insider trading. Rigel Pharmaceuticals, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Medical Officer Duliege Anne-Marie has sold 5,000 shares ... Leggi

Technical Reports on Generic Drugs Stocks -- Mylan, Allergan ... - PR Newswire (press release)

Stock-Callers.com has initiated coverage on select Generic Drugs stocks, particularly: Mylan N.V. (NASDAQ: MYL), Allergan PLC (NYSE: AGN), Horizon Pharma PLC (NASDAQ: HZNP), and Rigel Pharmaceuticals Inc. (NASDAQ: RIGL). These companies operate in the ... Leggi

Noticeable Buzzers: SUPERVALU Inc.'s (SVU), Rigel ... - Is stories

Rigel Pharmaceuticals, Inc. (RIGL) observed trading -9.35% away from the 20-day moving average and -13.61% off from its 50-day simple moving average. Recently, the stock has been moved -10.53% from its 200-day simple moving average.altro » Leggi

Analyst Views On Top Movers In Recent Trade: Teligent, Inc. (TLGT ... - Post Analyst

Teligent, Inc. (NASDAQ:TLGT) last session's volume of 0.3 million shares was lower than its average volume of 0.3 million shares. The stock, after opening at ... Leggi

Trading Options: Rigel Pharmaceuticals Inc (NASDAQ:RIGL) : A ... - CML News

While covered calls are one of the most commonly used option strategies, it turns out we need to be clever in how we treat earnings in order to maximize the strategy in Rigel Pharmaceuticals Inc (NASDAQ:RIGL) . Even further, if we don't do this ...altro » Leggi

Analyst Observation On 2 Stocks: Sangamo Therapeutics, Inc ... - Post Analyst

Turning to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), its shares were trading at $2.66 a retreat of $-0.02, on the trading floor. The stock, after opening at $2.67, touched a high of $2.7 before paring much of its gains. So far, analysts are sticking ...altro » Leggi